presentation and training materials using the MS Office (Word, PowerPoint, and Excel), Arthur, Review my eLearning and Snag-It... our national origination team of empowered advisors. At First National, It’s in our Nature is our rallying cry. It underlies...
practice with tools Ability to grasp general concepts in a field of testing and apply it to specific test methods... specific situations and to specific products. Accepts instruction and follows it for testing outside of their general scope...
or elder care or whatever it is you need to do to have a healthy balance of life and work. You have the freedom to set... vaccine and it has been 14 days since the last dose. SE Health is committed to the success of all its employees. If you feel...
. We take pride in doing good things for the environment to help create a greener, more sustainable future for all. It's simple...; we do it right. We AIM for excellence. What we offer! A competitive salary, vacation, benefits and a RRSP matching program...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »